Acolbifene
Acolbifene
Acolbifene (pronounced: a-kol-bi-feen) is a Selective Estrogen Receptor Modulator (SERM) that is primarily used in the treatment of breast cancer. It is a derivative of raloxifene, and is known for its antiestrogenic properties.
Etymology
The term 'Acolbifene' is derived from the chemical structure of the compound. The prefix 'Acol-' is derived from the chemical structure of the compound, which contains an acol group. The suffix '-fene' is a common suffix used in the nomenclature of SERMs, indicating its function as an estrogen receptor modulator.
Usage
Acolbifene is primarily used in the treatment of hormone-responsive breast cancer. It works by binding to estrogen receptors in the body, thereby blocking the effects of estrogen. This can help to slow the growth of certain types of breast cancer cells that require estrogen to grow.
Related Terms
- Selective Estrogen Receptor Modulator (SERM): A type of drug that acts on the estrogen receptor. SERMs can have either estrogenic or antiestrogenic effects, depending on the tissue.
- Breast Cancer: A type of cancer that forms in the cells of the breasts. It is the most common cancer in women worldwide.
- Estrogen: A group of hormones that play an important role in the normal sexual and reproductive development in women.
- Raloxifene: A SERM that is used to prevent and treat osteoporosis in postmenopausal women. It is also used to reduce the risk of invasive breast cancer in postmenopausal women who have osteoporosis or who are at risk of invasive breast cancer.
External links
- Medical encyclopedia article on Acolbifene
- Wikipedia's article - Acolbifene
This WikiMD article is a stub. You can help make it a full article.
Languages: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
Urdu,
বাংলা,
తెలుగు,
தமிழ்,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
European
español,
Deutsch,
français,
русский,
português do Brasil,
Italian,
polski